shortagewatch

Home / Nervous system / Rivastigmine

ATC N06DA03 · Psychoanaleptics

Rivastigmine shortage

As of 31 Oct 2026, Rivastigmine has a reported shortage in 4 of the 5 countries we track (Italy, Spain, Austria, Belgium), covering 16 products.

Countries4/5
Products16packs or presentations
Short since15 Oct 20215.0 years ago
Earliest return12 Nov 2026company estimate
No return date11products
Main reasonManufacturing problem

Timeline

ItalySpainAustriaBelgium
20222023202420252026RIVASTIGMINA ZENTIVARIVASTIGMINA ZENTIVANIMVASTIDNIMVASTIDRIVASTIGMINA ZENTIVARIVASTIGMINA ZENTIVARIVASTIGMINA ZENTIVARIVASTIGMINA ZENTIVARIVASTIGMINA ZENTIVARIVASTIGMINA ZENTIVANIMVASTIDNIMVASTIDNIMVASTIDNIMVASTIDRIVASTIGMINA MYLAN PHARMARIVASTIGMINA MYLAN PHARMARIVASTIGMINA AUROBINDORIVASTIGMINA AUROBINDORIVASTIGMINA STADAFARMA 4,5 MG CAPSULAS DURARIVASTIGMINA STADAFARMA 4,5 MG CAPSULAS DURAS EFG, 56 cápsulasNimvastid 1,5 mg Hartkapseln, 60 StückNimvastid 1,5 mg Hartkapseln, 60 StückNimvastid 6 mg Hartkapseln, 60 StückNimvastid 6 mg Hartkapseln, 60 StückRivastigmin Sandoz 4,6 mg/24 Stunden - transRivastigmin Sandoz 4,6 mg/24 Stunden - transdermales Pflaster, 30 StückNimvastid 3 mg Hartkapseln, 60 StückNimvastid 3 mg Hartkapseln, 60 StückRivastigmin Sandoz 9.5 mg/24 h transderm. paRivastigmin Sandoz 9.5 mg/24 h transderm. patch sachet 90 (3 x 30 (18 mg/10 cm²))today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITRIVASTIGMINA ZENTIVAZENTIVA ITALIA S.R.L.15 Oct 2021not givenManufacturing problem
Problemi produttivi: forniture discontinue
ITNIMVASTIDKRKA D.D. NOVO MESTO21 Mar 2024not givenManufacturing problem
Problemi produttivi
ITRIVASTIGMINA ZENTIVAZENTIVA ITALIA S.R.L.9 Sep 2024not givenIncreased demand
Elevata richiesta
ITRIVASTIGMINA ZENTIVAZENTIVA ITALIA S.R.L.31 Aug 2025not givenIncreased demand
Elevata richiesta/problemi produttivi
ITRIVASTIGMINA ZENTIVAZENTIVA ITALIA S.R.L.31 Aug 2025not givenIncreased demand
Elevata richiesta/problemi produttivi
ITNIMVASTIDKRKA D.D. NOVO MESTO6 Nov 2025not givenManufacturing problem
Problemi produttivi
ITNIMVASTIDKRKA D.D. NOVO MESTO3 Mar 2026not givenManufacturing problem
Problemi produttivi
ITRIVASTIGMINA MYLAN PHARMAMYLAN S.P.A.18 May 2026not givenManufacturing problem
Problemi produttivi
ITRIVASTIGMINA AUROBINDOAUROBINDO PHARMA (ITALIA) S.R.L.8 Oct 2026not givenManufacturing problem
Problemi produttivi
ITRIVASTIGMINA MYLAN PHARMA announcedMYLAN S.P.A.20 Dec 2026not givenManufacturing problem
Problemi produttivi
ESRIVASTIGMINA STADAFARMA 4,5 MG CAPSULAS DURAS EFG, 56 cápsulasLaboratorio Stada S.L.28 Apr 202612 Nov 2026Not stated
ATNimvastid 1,5 mg Hartkapseln, 60 StückKRKA d.d. Novo Mesto8 Sep 202630 Nov 2026Manufacturing problem
Verzögerung bei der Herstellung
ATNimvastid 6 mg Hartkapseln, 60 StückKRKA d.d. Novo Mesto8 Sep 202630 Nov 2026Manufacturing problem
Verzögerung bei der Herstellung
ATRivastigmin Sandoz 4,6 mg/24 Stunden - transdermales Pflaster, 30 StückSandoz GmbH14 Sep 2026not givenManufacturing problem
Kapazitätsengpässe bei der Herstellung
ATNimvastid 3 mg Hartkapseln, 60 StückKRKA d.d. Novo Mesto22 Oct 202630 Nov 2026Manufacturing problem
Verzögerung bei der Herstellung
BERivastigmin Sandoz 9.5 mg/24 h transderm. patch sachet 90 (3 x 30 (18 mg/10 cm²))Sandoz17 Jun 202613 Nov 2026Manufacturing problem
Delay in production

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply